HKSecWiki新股資訊 2022年02月11日
10:54 PM EST, 02/10/2022 (MT Newswires) -- PW Medtech Group (HKG:1358) placed an order to subscribe for roughly 10.9 million shares in the initial public offering of Lepu Biopharma (HKG:2157) for HK$81 million ($10.4 million).
Completion of the medical device maker's order is subject to the successful listing of Lepu Bio, which intends to disclose the allocations on Feb. 22 and start trading on the Hong Kong bourse a day after.
PW Medtech's late Thursday disclosure comes on the same day cancer-focused biopharmaceutical firm Lepu Biopharma launched its Hong Kong IPO.
Price (HKD): $1.10, Change: $0.00, Percent Change: 0.00%
本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠，亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。
作者：HKSecWiKi